HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Emoto, M. Articles by Kaufmann, S. H. E. Search for Related Content PubMed PubMed Citation Articles by Emoto, M. Articles by Kaufmann, S. H. E.

Critical Role of Leukocyte Function-Associated Antigen-1 in Liver Accumulation of CD4⁺NKT Cells¹

Masashi Emoto^*, Hans-Willi Mittrücker^*, Rudolf Schmits, Tak W. Mak and Stefan H. E. Kaufmann^2,*

^* Department of Immunology, Max-Planck-Institute for Infection Biology, Berlin, Germany; Department of Internal Medicine, University of Saarland, Homburg, Germany; and Departments of Medical Biophysics and Immunology, Ontario Cancer Institute and Amgen Institute, Toronto, Ontario, Canada

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
In contrast to peripheral lymphoid organs, a high percentage of T cells in the liver are CD4⁺NKT cells. We asked whether adhesion molecules play any role in the accumulation of CD4⁺NKT cells in the liver. Liver CD4⁺NKT cells expressed ICAM-1 and high levels of LFA-1. In the livers of LFA-1-deficient mice, the number of CD4⁺NKT cells was markedly decreased. This reduction was restricted to the liver, and no reduction was found in the other organs analyzed. In contrast, the number of liver CD4⁺NKT cells in ICAM-1-deficient mice was only marginally reduced. In a reciprocal radiation thymocyte reconstitution system with LFA-1-deficient and wild-type mice, LFA-1 expressed on liver cells other than CD4⁺NKT cells was required for an accumulation of CD4⁺NKT cells in the liver. These results demonstrate a crucial role for LFA-1 in the accumulation of CD4⁺NKT cells in the liver.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
NKT cells have been identified in the thymus and peripheral lymphoid organs of mice and show a wide variety of biological functions such as cytokine production and cytotoxicity (1). The proportion of NKT cells is markedly higher in the liver compared with other organs (2, 3), raising the possibility that these cells develop in the liver directly. Although there is still controversy over whether NKT cell development is thymus-dependent or -independent (1), it has been shown that the thymus is essential for the development of these cells (1, 3, 4, 5). NKT cells are controlled by ß₂-microglobulin (ß₂m)³-associated nonpolymorphic CD1 molecules, which are expressed on double-positive thymocytes at high density (2, 3, 4, 6, 7, 8, 9, 10). NKT cells mature in the absence of thymic epithelial cells (2, 6, 7, 8).

LFA-1 (CD11a/CD18) is a member of the ß₂ integrin family of cell adhesion molecules, which is expressed exclusively on leukocytes, albeit at different levels, and is involved in numerous immunological functions, including cell migration into tissues (11). ICAM-1 (CD54) was initially identified as a ligand for LFA-1 (11). Evidence has been presented that NKT cells in the thymus and lymph nodes express ICAM-1 and high levels of LFA-1 (10, 12, 13). Liver NKT cells have also been shown to express ICAM-1 and high levels of LFA-1 by indirect means (3, 14, 15). These findings raise the question of whether these cell adhesion molecules are involved in the accumulation of NKT cells in the liver.

In the present study, we analyzed the proportions of CD4⁺NKT cells in the livers of different mouse strains deficient in the expression of adhesion molecules to clarify the role of these molecules in the accumulation of CD4⁺NKT cells to the liver. The proportion of CD4⁺NKT cells in the liver was markedly reduced in LFA-1-deficient mice, whereas marginal reduction was observed in ICAM-1-deficient mice. Migration of CD4⁺NKT cells to the liver was observed in wild-type (wt) mice that had been irradiated and reconstituted with thymocytes from LFA-1-deficient mice. In contrast, liver migration was not observed in LFA-1-deficient mice that had been irradiated and reconstituted with thymocytes from wt mice. Our results demonstrate that the LFA-1 expressed on liver cells other than CD4⁺NKT cells plays a pivotal role in the accumulation of CD4⁺NKT cells in the liver and suggest that ICAM-1 is not essential for the residence of CD4⁺NKT cells in the liver.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
Mice

Breeding pairs of H-2I-Aß (Aß)^-/- mice were kindly provided by Dr. D. Mathis (Institut de Génétique et de Biologie Moleculaire et Cellulaire, Strasboug, France) (16). C57BL/6 scid/scid (SCID), ß₂m^-/-, and ICAM-1^-/- mice were purchased from The Jackson Laboratory (Bar Harbor, ME). LFA-1^-/- mice were generated by homologous recombination using 129/J-derived ES cell lines as described previously (17). Mutant mice were backcrossed to C57BL/6 (ß₂m^-/-, Aß^-/-, and ICAM-1^-/-: >8 generations; LFA-1^+/- and LFA-1^-/-: 3 generations). These mutants, as well as Thy1.1 congenic C57BL/6 (Thy1 congenic) and C57BL/6 wt mice, were maintained under specific pathogen-free conditions at our animal facilities at the Federal Institute for Health Protection of Consumers and Veterinary Medicine (Berlin, Germany) and were used at 2–6 mo of age.

Monoclonal Abs

The following mAbs were purified from hybridoma culture supernatants: anti-NK1.1 mAb (PK136), anti-FcR mAb (2.4G2), anti-TCRß mAb (H57-597), and anti-CD4 mAb (YTS191.1). Anti-NK1.1 mAb was biotinylated; anti-NK1.1 mAb, anti-TCRß mAb, and anti-CD4 mAb were conjugated with FITC. Phycoerythrin (PE)-conjugated anti-CD4 mAb (H129.19) and streptavidin (SA)-conjugated Red 670 were purchased from Life Technologies (Gaithersburg, MD). Biotinylated anti-CD11a (LFA-1) mAb (M17/4), FITC-conjugated anti-CD54 (ICAM-1) mAb (H9.2B8), FITC-conjugated anti-CD90.1 (Thy1.1) mAb (HIS51), and PE-conjugated anti-CD90.2 (Thy1.2) mAb (53-2.1) were obtained from PharMingen (Hamburg, Germany).

Cell preparation and flow cytometry

Liver mononuclear cells (LMNCs) and intestinal intraepithelial lymphocytes were prepared as described previously (3). Cells from the thymus, spleen, lymph nodes, and bone marrow were prepared by conventional methods. Peritoneal nonadherent cells were obtained as described previously (18). Cells were stained with appropriate dilutions of mAb. Biotinylated mAbs were visualized by SA-conjugated Red 670. Before staining, cells were incubated with 50 µg/ml anti-FcR mAb. Each staining step was performed at 4°C for 30 min; each washing step was performed with PBS containing 0.1% BSA and 0.1% sodium azide. After staining, cells were washed and subsequently fixed with 1% paraformaldehyde. Stained cells were acquired by FACScan (Becton Dickinson, Mountain View, CA), and lymphoid cells were analyzed with CellQuest software.

Radiation and thymocyte transfer

Thy1 congenic (Thy1.1⁺, LFA-1⁺) or LFA-1^-/- (Thy1.2⁺, LFA-1^-) mice were irradiated at 600 rad and reconstituted on day 2 with 3 x 10⁷ thymocytes from LFA-1^-/- or Thy1 congenic mice, respectively. Mice were killed 2 days after reconstitution, and the proportions of CD4⁺NK1⁺ T cells that migrated to the liver were monitored with anti-Thy1.1 or anti-Thy1.2 mAb by flow cytometry. SCID mice received 3 x 10⁷ thymocytes i.v. from LFA-1^+/- or LFA-1^-/- mice, and the proportions of CD4⁺NK1⁺ T cells that migrated to the liver were analyzed by flow cytometry 2 days after injection.

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
Expression of NK1.1, ICAM-1, or LFA-1 on CD4⁺ liver T cells

We first assessed the expression of NK1.1, ICAM-1, and LFA-1 molecules on CD4⁺ liver T cells. Consistent with previous findings (2, 3), a high proportion of NK1-expressing cells was identified within CD4⁺ liver T cells in C57BL/6 mice. This cell population was markedly reduced in ß₂m^-/- mice but remained virtually unaffected in Aß^-/- mice (Fig. 1). CD4⁺ liver T cells segregated into two main populations on the basis of ICAM-1 and LFA-1 expression: one population expressed ICAM-1 and/or high levels of LFA-1; the other did not. The relative proportion of ICAM-1-expressing CD4⁺ T cells and/or high levels of LFA-1-expressing CD4⁺ T cells were markedly reduced in ß₂m^-/- mice, but not in Aß^-/- mice (Fig. 1). Virtually all CD4⁺NK1⁺ T cells in the liver expressed ICAM-1 and high levels of LFA-1, whereas the majority of CD4⁺NK1^- liver T cells were devoid of ICAM-1 and expressed low levels of LFA-1 (Fig. 2). Consistent with previous findings (2, 3), virtually all CD4⁺NK1⁺ liver T cells expressed TCRß at an intermediate intensity (data not shown).

View larger version (40K): [in this window] [in a new window]   FIGURE 1. Expression of NK1.1, ICAM-1, and LFA-1 on CD4+ liver T cells from C57BL/6, ß2m-/-, and Aß-/- mice. LMNCs were stained with PE-conjugated anti-CD4 mAb and biotinylated anti-NK1.1 mAb, FITC-conjugated anti-ICAM-1 mAb, or biotinylated anti-LFA-1 mAb followed by SA-conjugated Red 670. Data are displayed as dot plots after gating on 5 x 103 small lymphoid cells. Numbers in dot plots represent the percentages of double-stained cells within small lymphoid cells. Representative results from four to six mice are shown.

View larger version (25K): [in this window] [in a new window]   FIGURE 2. Expression of ICAM-1 and LFA-1 on CD4+NK1+ and CD4+NK1- liver T cells. LMNCs from C57BL/6 mice were stained with PE-conjugated anti-CD4 mAb, biotinylated anti-NK1.1 mAb, and FITC-conjugated anti-ICAM-1 mAb or with PE-conjugated anti-CD4 mAb, FITC-conjugated anti-NK1.1 mAb, and biotinylated anti-LFA-1 mAb followed by SA-conjugated Red 670. Profiles are displayed as histograms after gating on 5 x 103 CD4+NK1+ or CD4+NK1- small lymphoid cells. Representative results from three mice are shown.

Because CD4⁺NKT cells in the liver expressed ICAM-1 and high levels of LFA-1, we wondered whether these molecules were involved in the accumulation of this cell population to the liver. To address this issue, we used ICAM-1^-/- or LFA-1^-/- mice. Representative results are shown in Fig. 3, and the results from four to six mice are summarized in Table I. Although the relative proportion of CD4⁺NK1⁺ T cells in the liver was only slightly reduced in ICAM-1^-/- mice, it was markedly diminished in LFA-1^-/- mice. The relative proportion of CD4⁺NK1^- T cells was not affected by LFA-1 deficiency (see Fig. 3). These results reveal that LFA-1 rather than ICAM-1 is crucial for the accumulation of CD4⁺NKT cells to the liver. The number of CD4⁺NK1⁺ T cells was slightly reduced in the livers of LFA-1^+/- mice compared with C57BL/6 mice. Because LFA-1 surface expression is slightly reduced in LFA-1^+/- mice compared with LFA-1^+/+ mice (17), we assume that the marginal reduction of CD4⁺NKT cells in LFA-1^+/- mice is caused by reduced LFA-1 surface expression.

View larger version (47K): [in this window] [in a new window]   FIGURE 3. Relative proportions of CD4+NK1+ T cells in livers of ICAM-1-/-, LFA-1-/-, LFA-1+/-, and C57BL/6 mice. LMNCs were stained with PE-conjugated anti-CD4 mAb and biotinylated anti-NK1.1 mAb followed by SA-conjugated Red 670. Data are displayed as dot plots after gating on 1 x 104 small lymphoid cells. Numbers in dot plots represent the percentages of CD4+NK1+ T cells within small lymphoid cells. Representative results from four to six mice are shown.

To determine whether LFA-1 is involved in the development of CD4⁺NKT cells, we assessed the presence of this cell population in lymphoid organs. The relative proportion of CD4⁺NK1⁺ T cells was virtually unaffected in all lymphoid organs of LFA-1^-/- mice compared with their heterozygous littermates (Fig. 4). We even observed a slight increase in the lymph nodes, spleen, and bone marrow of LFA-1^-/- mice. These results suggest that LFA-1 is not involved in the development of CD4⁺NKT cells but does play a central role in the recruitment of these cells to the liver.

View larger version (42K): [in this window] [in a new window]   FIGURE 4. Relative proportions of CD4+NK1+ T cells in the thymus, lymph nodes, spleen, intestinal intraepithelial lymphocytes (i-IEL), peritoneal cavity, and bone marrow from LFA-1+/- and LFA-1-/- mice. Cells were stained as described in Fig. 3. Data are displayed as dot plots after gating on 1 x 104 lymphoid cells. Numbers in dot plots represent the percentages of CD4+NK1+ T cells within lymphoid cells. Representative results from four to six mice are shown.

We wondered which cell type expressing LFA-1 (CD4⁺NKT cells or some other cells such as Kupffer cells, which have been found to express LFA-1 (19)) regulates the accumulation of CD4⁺NKT cells in the liver. Because virtually all CD4⁺NKT cells have been shown to express Thy1 (1, 3), we employed a reciprocal radiation thymocyte-reconstitution system with Thy1 congenic and LFA-1^-/- mice to address this issue. As shown in Fig. 5, a considerable population of CD4⁺NK1⁺ T cells derived from donor thymocytes (Thy1.2⁺) appeared in the livers of Thy1 congenic recipients that had been irradiated and reconstituted with thymocytes from LFA-1^-/- mice. Comparable results were obtained using C57BL/6 or Thy1 congenic mice that had been irradiated and reconstituted with thymocytes from Thy1 congenic or C57BL/6 mice, respectively (data not shown). In contrast, donor thymocyte-derived CD4⁺NK1⁺ T cells (Thy1.1⁺) were rare in the livers of LFA-1^-/- mice that had been irradiated and reconstituted with thymocytes from Thy1 congenic mice. Note that the migration efficiency of donor thymocytes to livers was similar in the two groups (Fig. 5). Consistent with these results, the proportions of donor thymocyte-derived CD4⁺NK1⁺ T cells in the livers of SCID mice that had received thymocytes from LFA-1^+/- or LFA-1^-/- mice were comparable (data not shown). These results suggest that the accumulation of CD4⁺NK1⁺ T cells in the liver is regulated by LFA-1 expressed on liver cells other than CD4⁺NKT cells, although CD4⁺NKT cells express high levels of LFA-1 themselves.

View larger version (27K): [in this window] [in a new window]   FIGURE 5. Proportions of donor thymocyte-derived CD4+NK1+ T cells in the livers of irradiated thymocyte-reconstituted mice. Thy1 congenic or LFA-1-/- mice were irradiated at 600 rad and reconstituted 2 days later with 3 x 107 thymocytes from LFA-1-/- or Thy1 congenic mice, respectively. LMNCs were prepared 2 days after reconstitution. Cells were stained with either FITC-conjugated anti-Thy1.1 mAb, PE-conjugated anti-CD4 mAb, and biotinylated anti-NK1.1 mAb or FITC-conjugated anti-CD4 mAb, PE-conjugated anti-Thy1.2 mAb, and biotinylated anti-NK1.1 mAb followed by SA-conjugated Red 670. Data of NK1.1/Thyl.2 and NK1.1/Thy1.1 are displayed as dot plots after gating on 2–3 x 104 total lymphoid cells. Numbers in dot plots represent the percentages of NK1.1+Thy1.2+ or NK1.1+Thy1.1+ cells within the total lymphoid population. The profiles of CD4 staining are displayed as histograms after gating on NK1.1+Thy1.2+ or NK1.1+Thy1.1+ lymphoid cells. Numbers in histograms represent the percentages of CD4+ cells within the NK1.1+Thy1.2+ or NK1.1+Thy1.1+ lymphoid populations. Representative results from two different experiments are shown.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

There is still controversy regarding whether NKT cells develop in a thymus-dependent or -independent manner (1). Because a markedly higher proportion of NKT cells has been identified in the liver compared with other organs (2, 3), it is possible that the liver is the major site for NKT cell development. Our data show that the accumulation of CD4⁺NKT cells in the liver is regulated by LFA-1 expression, suggesting accumulation to the liver of these cells or their precursors. Although one group has claimed higher numbers of NKT cells in the livers of nu/nu mice (20, 21, 22), other investigators including us were not able to identify NKT cells in nu/nu mice (1, 3, 23). Moreover, one study shows the development of NKT cells in fetal thymic organ cultures, and another report shows the requirement of CD1-expressing double-positive cortical thymocytes for the generation of NKT cells, suggesting thymus-dependent development (4, 6). While this work was under review, a paper was published in which the rapid regeneration of peripheral NKT cells was achieved via proliferation in the bone marrow after in vivo administration of anti-CD3 mAb or IL-12 even in the absence of the thymus (24). It is possible that bone marrow NKT cells proliferate and maintain homeostasis of peripheral NKT cells even in the absence of the thymus. However, it remains unclear whether NKT cell development in bone marrow is thymus-dependent under normal conditions. Our data show that thymic NKT cells migrate to the liver, suggesting that the thymus provides a reservoir for NKT cells in the periphery, at least in the liver. A comparison of CD1 expression on double-positive thymocytes from LFA-1^+/- and LFA-1^-/- mice revealed no difference (M.E., unpublished observation). Moreover, in thymus and peripheral lymphoid organs, the numbers of CD4⁺NKT cells were not reduced. These results not only exclude the possibility that the reduction of CD4⁺NKT cells in LFA-1^-/- mice involves CD1, but also suggest that CD4⁺NKT cells develop normally in the absence of LFA-1.

In summary, our data indicate a crucial role for LFA-1 in the accumulation of CD4⁺NKT cells in the liver. Although CD4⁺NKT cells express high levels of LFA-1, we find that LFA-1 on CD4⁺NKT cells is not required for liver accumulation. Rather, we demonstrate that LFA-1 on liver cells other than CD4⁺NKT cells is crucial for accumulation of the latter in the liver. Because Kupffer cells express LFA-1, they represent candidates for these cells (19).

	Acknowledgments

 
We thank Dr. D. Mathis for breeding pairs of gene-disruption mutants and Drs. R. Kubo, E. A. Harvell, H. Waldman, and M. Kronenberg for reagents. We express our appreciation to Drs. J. Zerrahn and T. Aebischer for helpful advice on the irradiation experiment. We are grateful to M. Stäber for mAb purification and K. Bordasch for mouse screening.

	Footnotes

 
¹ This work received financial support from the German Science Foundation. M.E. acknowledges additional financial support from Yamanouchi Foundation for Research on Metabolic Disorders.

² Address correspondence and reprint requests to Dr. Stefan H. E. Kaufmann, Max-Planck-Institute for Infection Biology, Monbijoustrasse 2, 10117 Berlin, Germany. E-mail address:

³ Abbreviations used in this paper: ß₂m, ß₂-microglobulin; Aß, H-2I-Aß; LMNC, liver mononuclear cell; PE, phycoerythrin; SA, streptavidin; wt, wild type.

Received for publication December 4, 1998. Accepted for publication February 5, 1999.

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 

1. Bendelac, A., M. N. Rivera, S.-H. Park, J. H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:535.[Medline]
2. Ohteki, T., H. R. MacDonald. 1994. Major histocompatibility complex class I related molecules control the development of CD4⁺8^- and CD4^-8^- subsets of natural killer 1.1⁺ T cell receptor-/ß⁺ cells in the liver of mice. J. Exp. Med. 180:699.[Abstract/Free Full Text]
3. Emoto, M., Y. Emoto, S. H. E. Kaufmann. 1995. IL-4-producing CD4⁺ TCRß^int liver lymphocytes: influence of thymus, ß₂-microglobulin, and NK1.1 expression. Int. Immunol. 7:1729.[Abstract/Free Full Text]
4. Bendelac, A.. 1995. Positive selection of mouse NK1⁺ T cells by CD1-expressing cortical thymocytes. J. Exp. Med. 182:2091.[Abstract/Free Full Text]
5. Nakagawa, K., K. Iwabuchi, K. Ogasawara, M. Ato, M. Kajiwara, H. Nishihori, C. Iwabuchi, H. Ishikura, R. A. Good, K. Onoé. 1997. Generation of NK1.1⁺ T cell antigen receptor /ß⁺ thymocytes associated with intact thymic structure. Proc. Natl. Acad. Sci. USA 94:2472.[Abstract/Free Full Text]
6. Bendelac, A., N. Killeen, D. R. Littman, R. H. Schwartz. 1994. A subset of CD4⁺ thymocytes selected by MHC class I molecules. Science 263:1774.[Abstract/Free Full Text]
7. Bix, M., M. Coles, D. Raulet. 1993. Positive selection of Vß8⁺CD4^-8^- thymocytes by class I molecules expressed by hematopoietic cells. J. Exp. Med. 178:901.[Abstract/Free Full Text]
8. Coles, M. C., D. H. Raulet. 1994. Class I dependence of the development of CD4⁺ CD8^- NK1.1⁺ thymocytes. J. Exp. Med. 180:395.[Abstract/Free Full Text]
9. Bendelac, A., O. Lantz, M. E. Quimby, J. W. Yewdell, J. R. Bennink, R. R. Brutkiewicz. 1995. CD1 recognition by mouse NK1⁺ T lymphocytes. Science 268:863.[Abstract/Free Full Text]
10. Cardell, S., S. Tangri, S. Chan, M. Kronenberg, C. Benoist, D. Mathis. 1995. CD1-restricted CD4⁺ T cells in major histocompatibility complex class II-deficient mice. J. Exp. Med. 182:993.[Abstract/Free Full Text]
11. Springer, T. A.. 1995. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu. Rev. Physiol. 57:827.[Medline]
12. Arase, H., N. Arase, K. Ogasawara, R. A. Good, K. Onoé. 1992. An NK1.1⁺ CD4⁺ 8^- single-positive thymocyte subpopulation that expresses a highly skewed T-cell antigen receptor Vß family. Proc. Natl. Acad. Sci. USA 89:6506.[Abstract/Free Full Text]
13. Arase, H., N. Arase-Fukushi, R. A. Good, K. Onoé. 1993. Lymphokine-activated killer cell activity of CD4^-CD8^- TCRß⁺ thymocytes. J. Immunol. 151:546.[Abstract]
14. Watanabe, H., K. Ohtsuka, M. Kimura, Y. Ikarashi, K. Ohmori, A. Kusumi, T. Ohteki, S. Seki, T. Abo. 1992. Details of an isolation method for hepatic lymphocytes in mice. J. Immunol. Methods 146:145.[Medline]
15. Matsumoto, Y., M. Emoto, J. Usami, K. Maeda, Y. Yoshikai. 1994. A protective role of extrathymic ß TcR cells in the liver in primary murine salmonellosis. Immunology 81:8.[Medline]
16. Cosgrove, D., D. Gray, A. Dierich, J. Kaufman, M. Lemeur, C. Benoist, D. Mathis. 1991. Mice lacking MHC class II molecules. Cell 66:1051.[Medline]
17. Schmits, R., T. M. Kündig, D. M. Baker, G. Shumaker, J. J. L. Simard, G. Duncan, A. Wakeham, A. Shahinian, A. van der Heiden, M. F. Bachmann, et al 1996. LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor. J. Exp. Med. 183:1415.[Abstract/Free Full Text]
18. Emoto, M., H. Danbara, Y. Yoshikai. 1992. Induction of / T cells in murine salmonellosis by an avirulent but not by a virulent strain of Salmonella choleraesuis. J. Exp. Med. 176:363.[Abstract/Free Full Text]
19. Myers, K. J., M. J. Eppihimer, L. Hall, B. Wolitzky. 1998. Interleukin-12-induced adhesion molecule expression in murine liver. Am. J. Pathol. 152:457.[Abstract]
20. Hashimoto, W., K. Takeda, R. Anzai, K. Ogasawara, H. Sakihara, K. Sugiura, S. Seki, K. Kumagai. 1995. Cytotoxic NK1.1 Ag⁺ ß T cells with intermediate TCR induced in the liver of mice by IL-12. J. Immunol. 154:4333.[Abstract]
21. Takahashi, M., K. Ogasawara, K. Takeda, W. Hashimoto, H. Sakihara, K. Kumagai, R. Anzai, M. Satoh, S. Seki. 1996. LPS induces NK1.1⁺ ß T cells with potent cytotoxicity in the liver of mice via production of IL-12 from Kupffer cells. J. Immunol. 156:2436.[Abstract]
22. Takeda, K., S. Seki, K. Ogasawara, R. Anzai, W. Hashimoto, K. Sugiura, M. Takahashi, M. Satoh, K. Kumagai. 1996. Liver NK1.1⁺ CD4⁺ ß T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis. J. Immunol. 156:3366.[Abstract]
23. Emoto, M., Y. Emoto, S. H. E. Kaufmann. 1997. TCR-mediated target cell lysis by CD4⁺NK1⁺ liver T lymphocytes. Int. Immunol. 4:563.[Abstract/Free Full Text]
24. Eberl, G., H. R. MacDonald. 1998. Rapid death and regeneration of NKT cells in anti-CD3- or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis. Immunity 9:345.[Medline]

This article has been cited by other articles:

				L. A. Monticelli, Y. Yang, J. Knell, L. M. D'Cruz, M. A. Cannarile, I. Engel, M. Kronenberg, and A. W. Goldrath Transcriptional regulator Id2 controls survival of hepatic NKT cells PNAS, November 17, 2009; 106(46): 19461 - 19466. [Abstract] [Full Text] [PDF]

				A. Astrakhan, H. D. Ochs, and D. J. Rawlings Wiskott-Aldrich Syndrome Protein Is Required for Homeostasis and Function of Invariant NKT Cells J. Immunol., June 15, 2009; 182(12): 7370 - 7380. [Abstract] [Full Text] [PDF]

				K.-i. Seino and M. Taniguchi Functionally distinct NKT cell subsets and subtypes J. Exp. Med., December 19, 2005; 202(12): 1623 - 1626. [Abstract] [Full Text] [PDF]

				G. Matsumoto, E. Kubota, Y. Omi, U. Lee, and J. M. Penninger Essential Role of LFA-1 in Activating Th2-Like Responses by {alpha}-Galactosylceramide-Activated NKT Cells J. Immunol., October 15, 2004; 173(8): 4976 - 4984. [Abstract] [Full Text] [PDF]

				O. Shibolet, Y. Kalish, A. Klein, R. Alper, L. Zolotarov, B. Thalenfeld, D. Engelhardt, E. Rabbani, and Y. Ilan Adoptive transfer of ex vivo immune-programmed NKT lymphocytes alleviates immune-mediated colitis J. Leukoc. Biol., January 1, 2004; 75(1): 76 - 86. [Abstract] [Full Text] [PDF]

				M. Emoto, M. Miyamoto, Y. Emoto, I. Yoshizawa, V. Brinkmann, N. van Rooijen, and S. H. E. Kaufmann Highly Biased Type 1 Immune Responses in Mice Deficient in LFA-1 in Listeria monocytogenes Infection Are Caused by Elevated IL-12 Production by Granulocytes J. Immunol., October 15, 2003; 171(8): 3970 - 3976. [Abstract] [Full Text] [PDF]

				M. Emoto, Y. Emoto, V. Brinkmann, M. Miyamoto, I. Yoshizawa, M. Staber, N. van Rooijen, A. Hamann, and S. H. E. Kaufmann Increased Resistance of LFA-1-Deficient Mice to Lipopolysaccharide-Induced Shock/Liver Injury in the Presence of TNF-{alpha} and IL-12 Is Mediated by IL-10: A Novel Role for LFA-1 in the Regulation of the Proinflammatory and Anti-Inflammatory Cytokine Balance J. Immunol., July 15, 2003; 171(2): 584 - 593. [Abstract] [Full Text] [PDF]

				G. Matsumoto, S. Tsunematsu, K.-i. Tsukinoki, Y. Ohmi, M. Iwamiya, A. Oliveira-dos-Santos, D. Tone, J. Shindo, and J. M. Penninger Essential Role of the Adhesion Receptor LFA-1 for T Cell-Dependent Fulminant Hepatitis J. Immunol., December 15, 2002; 169(12): 7087 - 7096. [Abstract] [Full Text] [PDF]

				K. Dunussi-Joannopoulos, K. Zuberek, K. Runyon, R. G. Hawley, A. Wong, J. Erickson, S. Herrmann, and J. P. Leonard Efficacious immunomodulatory activity of the chemokine stromal cell-derived factor 1 (SDF-1): local secretion of SDF-1 at the tumor site serves as T-cell chemoattractant and mediates T-cell-dependent antitumor responses Blood, August 13, 2002; 100(5): 1551 - 1558. [Abstract] [Full Text] [PDF]

				M. K. Mannoor, R. C. Halder, S. R. M. Morshed, A. Ariyasinghe, H. Y. Bakir, H. Kawamura, H. Watanabe, H. Sekikawa, and T. Abo Essential Role of Extrathymic T Cells in Protection Against Malaria J. Immunol., July 1, 2002; 169(1): 301 - 306. [Abstract] [Full Text] [PDF]

				I. Apostolou, A. Cumano, G. Gachelin, and P. Kourilsky Evidence for Two Subgroups of CD4-CD8- NKT Cells with Distinct TCR{alpha}{beta} Repertoires and Differential Distribution in Lymphoid Tissues J. Immunol., September 1, 2000; 165(5): 2481 - 2490. [Abstract] [Full Text] [PDF]

				M. Miyamoto, M. Emoto, V. Brinkmann, N. van Rooijen, R. Schmits, E. Kita, and S. H. E. Kaufmann Cutting Edge: Contribution of NK Cells to the Homing of Thymic CD4+NKT Cells to the Liver J. Immunol., August 15, 2000; 165(4): 1729 - 1732. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Emoto, M. Articles by Kaufmann, S. H. E. Search for Related Content PubMed PubMed Citation Articles by Emoto, M. Articles by Kaufmann, S. H. E.